| Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
|---|
| 09/10/2013 | US8530669 Ester compound and use thereof |
| 09/10/2013 | US8530506 Process for production of biphenyl derivative |
| 09/10/2013 | CA2611376C Therapeutic agents |
| 09/10/2013 | CA2590687C Process for preparing voriconazole |
| 09/06/2013 | WO2013127949A1 Functional pla-peg copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging |
| 09/06/2013 | WO2013127361A1 Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers |
| 09/05/2013 | US20130231489 Novel organometallic complexes which emit in the red to green spectral region and their use in oleds |
| 09/05/2013 | US20130231488 Process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds; use of the said compounds obtained via the process in the synthesis of siloxane compounds containing a 2-hydroxyphenylbenzotriazole function |
| 09/05/2013 | US20130231333 Estrogen receptor modulators and uses thereof |
| 09/05/2013 | US20130231323 Ethynylbenzene derivatives |
| 09/05/2013 | US20130231313 Substituted phenylacetate and phenylpropane amides and use thereof |
| 09/04/2013 | EP2634179A1 Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging |
| 09/04/2013 | EP2632905A1 Process for preparing 2-hydroxyphenyl benzotriazole siloxane compounds |
| 09/04/2013 | EP2632904A1 Process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds and process for preparing siloxane compounds containing 2-hydroxyphenyl benzotrizole function |
| 09/04/2013 | CN103282354A N-(tetrazol-5-l)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides |
| 09/04/2013 | CN103275024A Azole antifungal compound and its preparation method and application |
| 09/04/2013 | CN103275023A 1- aryl-1, 2, 3-triazole compound, as well as preparation method and application thereof |
| 09/04/2013 | CN103275022A 1-benzyl-1, 2, 3-triazole compound, as well as preparation method and application thereof |
| 09/04/2013 | CN103275013A Novel nitrogenous heterocycle sulfamide derivative type aromatizing enzyme inhibitor and preparation method thereof |
| 09/04/2013 | CN102089290B Triazole derivatives useful for the treatment of diseases |
| 09/03/2013 | US8524754 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate, and uses thereof |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 08/29/2013 | US20130225646 Substituted n-phenethyltriazoloneacetamides and use thereof |
| 08/29/2013 | US20130225619 Substituted heterocyclic compounds for disease treatment |
| 08/28/2013 | EP2629616A2 Substituted amino-triazolyl pde10 inhibitors |
| 08/28/2013 | CN103265499A Refining method of 5- methoxyl-4-methyl-2, 4- dihydro-3H-1, 2, 4- triazole-3-ketone |
| 08/27/2013 | US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 08/27/2013 | US8518942 Caspase inhibitors and uses thereof |
| 08/27/2013 | CA2657776C Triazolyl phenyl benzenesulfonamides |
| 08/22/2013 | WO2013123222A1 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds |
| 08/22/2013 | US20130217887 Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof |
| 08/22/2013 | US20130216475 Methods and compositions for protein labelling |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261168A Neprilysin inhibitors |
| 08/21/2013 | CN103261164A Neprilysin inhibitors |
| 08/20/2013 | US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/15/2013 | WO2013118986A1 Triazolopyridine derivatives as a tyrosine kinase inhibitor |
| 08/15/2013 | WO2013117629A1 Process for preparing cis-5-[1-(4-chlorophenyl)-methylene]-1-hydroxymethyl-2,2-dimethylcyclopentanol |
| 08/15/2013 | US20130210874 Dual-acting antihypertensive agents |
| 08/14/2013 | CN103242298A 1,2,4-triazole derivative, preparation method and application thereof and organic electroluminescent device |
| 08/14/2013 | CN103242252A Synthetic process of carboxyl benzotriazole |
| 08/14/2013 | CN103242251A Preparation method of letrozole |
| 08/14/2013 | CN101171239B 场致发光器件 Electroluminescent device |
| 08/13/2013 | US8506993 Compositions and methods for making and using multifunctional polymerized liposomes |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/08/2013 | US20130203826 Pure Intermediate |
| 08/08/2013 | US20130203593 Pesticidal compositions and processes related thereto |
| 08/08/2013 | US20130203592 Pesticidal compositions and processes related thereto |
| 08/07/2013 | EP2623499A1 1,2,4-triazolone derivative |
| 08/07/2013 | EP2621905A2 Methods including latent 1,3-dipole-functional compounds and materials prepared thereby |
| 08/07/2013 | EP2621877A1 Process for preparing 5-[1-(4-chlorophenyl)-methylene]-1-hydroxymethyl-2,2-dimethyl-cyclopentanol |
| 08/06/2013 | US8501790 Compounds for the treatment of proliferative disorders |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | CA2563180C Non-nucleoside reverse transcriptase inhibitors |
| 08/01/2013 | WO2013083859A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides |
| 08/01/2013 | US20130197217 1, 2, 4-triazolone derivative |
| 08/01/2013 | US20130197178 Crystalline 1h-1,2,3-triazol-5-ylidenes |
| 08/01/2013 | US20130194693 Magnetic media and magnetic recording devices using fluorine compounds |
| 07/31/2013 | EP2619188A1 Substituted n-phenethyltriazoloneacetamides and use thereof |
| 07/30/2013 | US8497278 Imidazo[1,2-a]pyridine compounds |
| 07/30/2013 | CA2547410C 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 07/25/2013 | WO2013108800A1 Substituted phenylazole derivative |
| 07/25/2013 | WO2013108514A1 Production method for cyclopentanone derivative, intermediate compound, and production method for intermediate compound |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013016531A3 Compounds and methods for use in treating neoplasia and cancer |
| 07/25/2013 | US20130190371 Fungicide Active Substance Combinations |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/24/2013 | EP2616448A1 Substituted phenylacetate and phenylpropane amides and use thereof |
| 07/24/2013 | EP2616445A2 Estrogen receptor modulators and uses thereof |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN103214398A Method for preparing carbamate |
| 07/24/2013 | CN101402613B Substituted phenoxy oxygen alkylamine triazole alcohol antimycotic compounds and method of preparing the same |
| 07/23/2013 | CA2542695C Substituted benzylaminoalkylene heterocycles |
| 07/18/2013 | WO2013105029A1 Process for preparation of rufinamide |
| 07/18/2013 | WO2013104705A1 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides |
| 07/18/2013 | US20130184470 Process for preparing 5-[1-(4-chlorophenyl)-methylene]-1-hydroxymethyl-2,2-dimethyl-cyclopentanol |
| 07/18/2013 | US20130184469 Process for preparation of rufinamide |
| 07/18/2013 | US20130184309 Metalloenzyme inhibitor compounds |
| 07/18/2013 | US20130184248 Novel compounds |
| 07/17/2013 | EP2614824A1 Therapeutic agent for pain |
| 07/17/2013 | EP2614052A1 Novel piperazine analogs as broad-spectrum influenza antivirals |
| 07/17/2013 | EP2614046A1 Novel guanidine derivatives in the cinnamic series |
| 07/17/2013 | CN103204820A 3-triazolyl-substituted-1-propylene compound and synthetic method thereof |
| 07/17/2013 | CN103204781A 2, 7-bi-substituted fluorenone derivative and preparation method and application thereof |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486977 1,2,3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors |
| 07/16/2013 | US8486932 Triazole compounds that modulate Hsp90 activity |
| 07/10/2013 | EP2611785A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides |
| 07/10/2013 | CN103201268A Novel piperazine analogs as broad-spectrum influenza antivirals |
| 07/10/2013 | CN103201243A Process for preparing 5-[1-(4-chlorophenyl)-methylene]-1-hydroxymethyl-2,2-dimethyl-cyclopentanol |
| 07/10/2013 | CN103196874A Aggregation-induced emission (AIE) illuminant?Cbased urine protein detection device for monitoring health of people |
| 07/10/2013 | CN103193724A Preparation method of 2,2'-methylenebis[6-(2H-benzotriazole-2-yl)-4-tertiary butyl] phenol as ultraviolet light absorber |
| 07/10/2013 | CN103193723A Benzotriazole Schiff base compound and preparation method thereof |
| 07/10/2013 | CN103193691A Sulfonamide compound and medicinal compositions thereof, and preparation methods and applications thereof |
| 07/10/2013 | CN102775362B Cooling crystallization method of H-benzotriazole |
| 07/10/2013 | CN102070541B Letrozole I-type crystal and preparation method thereof |
| 07/09/2013 | US8481749 N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamides and their use as herbicides |
| 07/09/2013 | US8481581 S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase |
| 07/09/2013 | US8481580 interleukin 1, 12, tumor necrosis factor alpha, and trigger interferon- gamma antagonist; antiinflammatory , antidiabetic agent, autoimmune disorders; active side chain moiety (5-R-hydroxyhexyl) of lisofyllin, greater potency and oral bioavailability than lisofylline |